The goal of the study is to evaluate how safe and how well the body handles GSK5458514 when administered in participants with prostate cancer. The study will b…

Neoplasms, Prostate

~Estimated

~$10 – $7,500

GlaxoSmithKlineNCT06990880

Phase 1

A Phase 1/2 First-Time-in-Human, Open-label, Multicenter, Dose Escalation and Dose Optimization Study of GSK5471713 in Adult Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)

This first-time-in-human study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, preliminary clinical activity, and establish the ben…

Neoplasms, Prostate

~Estimated

~$10 – $7,500

GlaxoSmithKlineNCT07332455

Observational

Investigation of Impact of AI on Prostate Cancer Workflow

This study will enroll participants who are undergoing an MRI before a prostate biopsy due to suspected prostate cancer. The purpose of this study is to see if…

Prostate CancerProstatic NeoplasmCancer of the Prostate+1 more

~Estimated

~$10 – $6,250

Case Comprehensive Cancer CenterNCT07084779